Stroke study seeks to personalize statin therapy
NCT ID NCT07344610
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study is observing 800 people who recently had an ischemic stroke or have significant artery narrowing. All are taking high doses of statins (atorvastatin or rosuvastatin) for at least a week. Researchers want to see how much their cholesterol drops and what factors influence that drop, to help guide future personalized treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- atorvastatin or rosuvastatin
- What this could lead to
- If successful, this could help doctors tailor statin doses to individual patients after a stroke, potentially improving prevention of future strokes.
- What could go wrong
- This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may vary widely among patients and may not apply to all stroke types.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Lu Wang
RECRUITINGShenyang, Liaoning, 110840, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Zapping the brain to restore swallowing after stroke?
- Can Brain-Triggered stimulation reawaken arms after stroke?
- Can lifestyle choices after a stroke extend life and prevent a second one?
- Can Clot-Removing devices improve stroke recovery?
- A tiny neck implant could catch Stroke-Causing clots before they reach the brain
- Can virtual games retrain the brain to restore balance?